Literature DB >> 19855099

Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor kappaB.

Johann Meunier1, Teruo Hayashi.   

Abstract

The expression of Bcl-2, the major antiapoptotic member of the Bcl-2 family, is under complex controls of several factors, including reactive oxygen species (ROS). The sigma-1 receptor (Sig-1R), which was recently identified as a novel molecular chaperone at the mitochondria-associated endoplasmic reticulum membrane (MAM), has been shown to exert robust cellular protective actions. However, mechanisms underlying the antiapoptotic action of the Sig-1R remain to be clarified. Here, we found that the Sig-1R promotes cellular survival by regulating the Bcl-2 expression in Chinese hamster ovary cells. Although both Sig-1Rs and Bcl-2 are highly enriched at the MAM, Sig-1Rs neither associate physically with Bcl-2 nor regulate stability of Bcl-2 proteins. However, Sig-1Rs tonically regulate the expression of Bcl-2 proteins. Knockdown of Sig-1Rs down-regulates whereas overexpression of Sig-1Rs up-regulates bcl-2 mRNA, indicating that the Sig-1R transcriptionally regulates the expression of Bcl-2. The effect of Sig-1R small interfering RNA down-regulating Bcl-2 was blocked by ROS scavengers and by the inhibitor of the ROS-inducible transcription factor nuclear factor kappaB (NF-kappaB). Knockdown of Sig-1Rs up-regulates p105, the precursor of NF-kappaB, while concomitantly decreasing inhibitor of nuclear factor-kappaBalpha. Sig-1R knockdown also accelerates the conversion of p105 to the active form p50. Lastly, we showed that knockdown of Sig-1Rs potentiates H(2)O(2)-induced apoptosis; the action is blocked by either the NF-kappaB inhibitor oridonin or overexpression of Bcl-2. Thus, these findings suggest that Sig-1Rs promote cell survival, at least in part, by transcriptionally regulating Bcl-2 expression via the ROS/NF-kappaB pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19855099      PMCID: PMC2812109          DOI: 10.1124/jpet.109.160960

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  39 in total

Review 1.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

2.  Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL.

Authors:  T Heinemeyer; E Wingender; I Reuter; H Hermjakob; A E Kel; O V Kel; E V Ignatieva; E A Ananko; O A Podkolodnaya; F A Kolpakov; N L Podkolodny; N A Kolchanov
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

3.  Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity.

Authors:  Agostino Marrazzo; Filippo Caraci; Elisa Trovato Salinaro; Tsung-Ping Su; Agata Copani; Giuseppe Ronsisvalle
Journal:  Neuroreport       Date:  2005-08-01       Impact factor: 1.837

4.  Effects of UMB24 and (+/-)-SM 21, putative sigma2-preferring antagonists, on behavioral toxic and stimulant effects of cocaine in mice.

Authors:  Rae R Matsumoto; Buddy Pouw; Aisha L Mack; Antawan Daniels; Andrew Coop
Journal:  Pharmacol Biochem Behav       Date:  2006-12-22       Impact factor: 3.533

5.  The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor.

Authors:  J Meunier; J Ieni; T Maurice
Journal:  Br J Pharmacol       Date:  2006-10-23       Impact factor: 8.739

6.  Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways.

Authors:  Takayuki Ikezoe; Yang Yang; Kentaro Bandobashi; Tsuyako Saito; Shigeki Takemoto; Hisanori Machida; Kazuto Togitani; H Phillip Koeffler; Hirokuni Taguchi
Journal:  Mol Cancer Ther       Date:  2005-04       Impact factor: 6.261

7.  Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival.

Authors:  Teruo Hayashi; Tsung-Ping Su
Journal:  Cell       Date:  2007-11-02       Impact factor: 41.582

8.  Sigma receptor agonists provide neuroprotection in vitro by preserving bcl-2.

Authors:  Sufang Yang; Anish Bhardwaj; Jian Cheng; Nabil J Alkayed; Patricia D Hurn; Jeffrey R Kirsch
Journal:  Anesth Analg       Date:  2007-05       Impact factor: 5.108

9.  A prototypical Sigma-1 receptor antagonist protects against brain ischemia.

Authors:  John A Schetz; Evelyn Perez; Ran Liu; Shiuhwei Chen; Ivan Lee; James W Simpkins
Journal:  Brain Res       Date:  2007-09-12       Impact factor: 3.252

Review 10.  Bcl-2 and Ca2+ homeostasis in the endoplasmic reticulum.

Authors:  P Pinton; R Rizzuto
Journal:  Cell Death Differ       Date:  2006-05-26       Impact factor: 15.828

View more
  46 in total

Review 1.  Apoptosis and aging: increased resistance to apoptosis enhances the aging process.

Authors:  Antero Salminen; Johanna Ojala; Kai Kaarniranta
Journal:  Cell Mol Life Sci       Date:  2010-11-30       Impact factor: 9.261

2.  The sigma-1 receptor chaperone as an inter-organelle signaling modulator.

Authors:  Tsung-Ping Su; Teruo Hayashi; Tangui Maurice; Shilpa Buch; Arnold E Ruoho
Journal:  Trends Pharmacol Sci       Date:  2010-10-01       Impact factor: 14.819

Review 3.  Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders.

Authors:  Teruo Hayashi; Shang-Yi Tsai; Tomohisa Mori; Michiko Fujimoto; Tsung-Ping Su
Journal:  Expert Opin Ther Targets       Date:  2011-03-05       Impact factor: 6.902

Review 4.  Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders.

Authors:  Shang-Yi A Tsai; Michael J Pokrass; Neal R Klauer; Nicole E De Credico; Tsung-Ping Su
Journal:  Expert Opin Ther Targets       Date:  2014-10-21       Impact factor: 6.902

5.  Oridonin Inhibits Cell Proliferation and Induces Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes.

Authors:  Cai-hong Shang; Qing-qing Zhang; Jian-hua Zhou
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

6.  The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements.

Authors:  Arindam Pal; Dominique Fontanilla; Anupama Gopalakrishnan; Young-Kee Chae; John L Markley; Arnold E Ruoho
Journal:  Eur J Pharmacol       Date:  2012-02-22       Impact factor: 4.432

Review 7.  Sigma receptors as potential therapeutic targets for neuroprotection.

Authors:  Linda Nguyen; Nidhi Kaushal; Matthew J Robson; Rae R Matsumoto
Journal:  Eur J Pharmacol       Date:  2014-09-27       Impact factor: 4.432

8.  Blockade of Tau hyperphosphorylation and Aβ₁₋₄₂ generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and σ₁ receptor agonist, in a nontransgenic mouse model of Alzheimer's disease.

Authors:  Valentine Lahmy; Johann Meunier; Susanna Malmström; Gaelle Naert; Laurent Givalois; Seung Hyun Kim; Vanessa Villard; Alexandre Vamvakides; Tangui Maurice
Journal:  Neuropsychopharmacology       Date:  2013-03-14       Impact factor: 7.853

9.  Sigma receptor 1 modulates ER stress and Bcl2 in murine retina.

Authors:  Yonju Ha; Arul K Shanmugam; Shanu Markand; Eric Zorrilla; Vadivel Ganapathy; Sylvia B Smith
Journal:  Cell Tissue Res       Date:  2014-01-28       Impact factor: 5.249

10.  In vitro evaluation of guanidine analogs as sigma receptor ligands for potential anti-stroke therapeutics.

Authors:  Adam A Behensky; Michelle Cortes-Salva; Michael J Seminerio; Rae R Matsumoto; Jon C Antilla; Javier Cuevas
Journal:  J Pharmacol Exp Ther       Date:  2012-10-12       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.